(2022) Evaluation of ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels in hospitalized COVID-19 patients with mucormycosis. Health Biotechnology and Biopharma. pp. 43-51.
Text
article_152627_583f6b58ac3c6057b9b6a459741e562b.pdf Download (7kB) |
Abstract
Mucormycosis in COVID-19 patients of severe type has been reported. This study was intended to evaluate ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels in COVID-19 patients with mucormycosis. Information was recorded including gender, age, hospitalization and recovery. The laboratory parameters contained ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels. There was a significant relationship between LDH and CPK level with hospitalization, and also, between CRP and gender. Finally, there was a significant difference between the age groups in terms of ESR. Our study showed that LDH and CPK, CRP and ESR should be considered as laboratory tests in the hospitalized COVID-19 patients with mucormycosis. © 2022, Health Biotechnology and Biopharma.
Item Type: | Article |
---|---|
Page Range: | pp. 43-51 |
Journal or Publication Title: | Health Biotechnology and Biopharma |
Volume: | 6 |
Number: | 2 |
Publisher: | Health Biotechnology And Biopharma |
Depositing User: | ms soheila Bazm |
URI: | http://eprints.ssu.ac.ir/id/eprint/13032 |
Actions (login required)
View Item |